id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-342588-berrojmq	Burri, Christian	Sleeping Sickness at the Crossroads	2020-04-08		.txt	text/plain	5879	240	46	The development of this orally active compound is described in detail in the papers of Neau et al., and Dickie et al., Fexinidazole received a positive scientific opinion from the European Medicines Agency for treatment of Gambiense HAT in late 2018, it was approved by the drug regulatory authority of the DRC and added to the WHO list of essential medicines in 2019, and the first official application in the DRC happened at the end of January 2020 on World NTD day in a public ceremony. In 2012, the World Health Organization, which has played an instrumental role in the control, set the goal for the elimination of human African trypanosomiasis (HAT), caused by Trypanosoma brucei gambiense (gHAT), as a public health problem for 2020 and for the total interruption of transmission to humans for 2030.	./cache/cord-342588-berrojmq.txt	./txt/cord-342588-berrojmq.txt